Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ç÷û PSA¿¡ µû¸¥ Àü¸³¼± »ý°ËÁ¶Á÷°ú ±ÙÄ¡Àû Àü¸³¼±ÀûÃâ¼ú Á¶Á÷ÀÇ Gleason Score ÀÏÄ¡µµ ºñ±³ Use of Serum PSA in Comparison of Biopsy Gleason Score with Radical Prostatectomy Gleason Score

´ëÇѺñ´¢±â°úÇÐȸÁö 1998³â 39±Ç 12È£ p.1241 ~ 1247
¼Ò¼Ó »ó¼¼Á¤º¸
±èû¼ö ¹Ú¹Î¼ö/Á¤ÇÑ/±èÅÂÈ¿/È«ÁØÇõ/¹ÚÇü±Ù/Á¤Áø¼ö/¹Ú³ëÁ¤/¹ÚÅÂÇÑ

Abstract

°á·Ð
Àü¸³¼± »ý°Ë¿¡¼­ÀÇ Gleason score°¡ °íºÐÈ­µµÀÎ °æ¿ì ¼úÈÄ Gleason score¿Í ÀÏÄ¡µµ°¡ ³·Àº
¹Ý¸é ÀúºÐÈ­µµ¿¡¼­´Â ±× ÀÏÄ¡µµ°¡ ³ô°í, ¼úÀü Ç÷û PSAÄ¡´Â ¼úÈÄ º´¸®Á¶Á÷ Gleason scope
¿Í ³ôÀº °ü·Ãµµ°¡ ÀÖÀ½À» ¾Ë ¼ö ÀÖ¾ú´Ù. º» ¿¬±¸¿¡¼­´Â ¼úÈÄ ÃÖÁ¾º´±â¸¦ ¿¹ÃøÇÏ´Â ÀÎÀڷμ­
±¹¼ÒÀü¸³¼±¾Ï¿¡ µ¥ÇÑ ¿¹ÃøÀº Ç÷û PSA°¡ ¿ì¼öÇÏ¿´°í, °ñ¹Ý³» ÀÓÆļ± ÀüÀÌ¿¡ ´ëÇÑ ¿¹Ãøµµ´Â
¼úÀü Á¶Á÷»ý°ËÀÇ Gleason scope°¡ ¿ì¼öÇÏ¿´´Ù. ¶ÇÇÑ, »ý°ËÁ¶Á÷ Gleason scope°¡ °íºÐÈ­µµÀÏ
¶§ ¼úÈÄ º´¸®Á¶Á÷ Gleason scope°¡ 44.4%¿¡¼­ upgradingµÇ¾úÀ¸¸ç, ƯÈ÷ Ç÷û PSA°¡
30ng/m1 ÀÌ»óÀÏ °æ¿ì¿¡´Â upgradingµÉ °¡´É¼ºÀÌ ´õ¿í ³ô¾ÆÁ³´Ù µû¶ó¼­ Àü¸³¼±¾Ï ȯÀÚÀÇ Ä¡
·á´Â Ç÷û PSAÄ¡¸¦ Âü°í·Î ÇÏ¿© PSA°¡ 20ng/ml ÀÌ»óÀÎ °æ¿ì »ý°ËÁ¶Á÷ÀÇ Gleason score°¡
¼úÈÄ Gleason score¿¡¼­ upgradingµÉ ¼ö ÀÖ´Ù´Â Á¡À» ÃæºÐÈ÷ °í·ÁÇÏ¿©¾ß Çϸç, ¼úÀü ±¹¼ÒÀü
¸³¼±¾ÏÀ¸·Î »ý°¢µÇ¾îÁø °æ¿ì¶óµµ Ç÷û PSA°¡ ³ôÀº °æ¿ì¿¡ ¼úÈÄ Àý°³¸é ħÅõ, ÇǸ·Ä§¹ü µî
upstaging °¡´É¼ºÀ» »ý°¢ÇÏ°í Ä¡·á½Ã¿¡ º¸´Ù Á¤È®ÇÑ ¼ö¼úÀû Á¢±ÙÀ» ÇÏ¿©¾ß ÇÒ °ÍÀ¸·Î »ý°¢
µÈ´Ù.
#ÃÊ·Ï#
Purpose : The Gleason score of needle biopsies of the prostate and preoperative serum
level of prostate-specific antigen(PSA) are two useful factors in predicting the final
pathological staging of patients with prostate cancer treated by radical prostatectomy.
Unfortunately, the Gleason score of the biopsy cores often differs from the Gleason
score of radical prostatectomy specimen. We evaluated the role of Gleason scores of
biopsy cores and the influence of PSA in predicting the Gleason scores of prostatectomy
specimens and final pathological staging.
Materials and Methods : The records of 52 patients with prostate cancer treated by
radical prostatectomy from June 1990 to June 1997 were reviewed. The patients were
divided into three groups according to the sum of the Gleason scores, i.e. well
differentiated(Gleason score 2-4), intermediate(5-7) and poorly differentiated
tumors(8-10). The concordance between Gleason score of biopsy and prostatectomy
specimen was analysed according to the Gleason score of tumor in biopsy specimen.
Furthermore, we evaluated the different level of PSA could affect the concordance rate
between Gleason scoreofbiopsyandprostatectomyspecimen.
Results : In well-differentiated tumors(Gleason score 2-4) in biopsy specimen, the
concordance rate was 55.6%, In intermediate(5-7) differentiated cancers the Gleason
score remained the same in 68%. In poorly differentiated tumors, the concordance rate
was 72.2%. When PSA was less than 10ng/m1, concordance rate of well differentiated
tumors and poorly differentiated tumors was 75%, 40%, respectively. Whereas the
concordance rate of well differentiated tumors was 50% and that of poorly differentiated
tumors was 90% when the PSA was higher than 20ng/m1. Using linear regression
analysis, the preoperative PSA highly correlated with radical prostatectomy Gleason
score(correlation coefficient(r)=0.38, p =0.005).
Conclusions : The Gleason score of prostatectomy specimen was upgraded in 44.4%
when the biopsy Gleason score was well differentiated, especially when preoperative
PSA was higher than 20ng/m1. Therefore, the significance of biopsy Gleason score in
the clinical application must be used cautiously when it is used to predict the
pathological stage or biological potential of the cancer especially when it is low Gleason
score with high PSA(>20ng/m1). In the meantime, the level of PSA plays an significant
role in determining organ confined disease, while high Gleason scone reflect the Iymph
node positive disease.

Å°¿öµå

Prostate biopsy; Radical prostatectomy; Gleason score; Prostate specif;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS